Bariatric–metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trialOrnella Verrastro, Geltrude Mingrone, James Casella-Mariolo et al.|The Lancet|2023Cited by 338
Long-term Relapse of Type 2 Diabetes After Roux-en-Y Gastric Bypass: Prediction and Clinical RelevanceJean Debédat, Judith Aron‐Wisnewsky, Nataliya Sokolovska et al.|Diabetes Care|2018Cited by 137
Accurate liquid biopsy for the diagnosis of non-alcoholic steatohepatitis and liver fibrosisGiulia Angelini, Geltrude Mingrone, Simona Panunzi et al.|Gut|2022Cited by 55
Dodecanedioic acid prevents and reverses metabolic‐associated liver disease and obesity and ameliorates liver fibrosis in a rodent model of diet‐induced obesityGiulia Angelini, Geltrude Mingrone, Sara Russo et al.|The FASEB Journal|2024Cited by 8
Performance of Noninvasive Tests for Metabolic Dysfunction-Associated Steatohepatitis and Liver Fibrosis Resolution after Bariatric SurgeryGiulia Angelini, Royce P Vincent, Simona Panunzi et al.|Clinical Chemistry|2024Cited by 2